4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-031164
Chief Financial Officer gave up 910 shares (to pay taxes)
- Chief Financial Officer acquired 2,336 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-05-18 | Option exercise | +2,336 | 98,333 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2022-05-18 | Shares withheld for taxes | −910 | $9.65 | $8,782 | 97,423 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2022-05-18 | Option exercise · Restricted Stock Units | −2,336 | 25,706 | D | ||
Loading xslF345X03/doc4.xml…